1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/26/2024 | CE | Buy Now | Celanese | $162.31 | 1.66% | RBC Capital | Arun Viswanathan | $168 → $165 | Maintains | Outperform | Get Alert |
02/26/2024 | CE | Buy Now | Celanese | $162.31 | 4.74% | Piper Sandler | Charles Neivert | $135 → $170 | Upgrade | Neutral → Overweight | Get Alert |
02/22/2024 | CE | Buy Now | Celanese | $162.31 | 1.66% | Baird | Ghansham Panjabi | $135 → $165 | Maintains | Outperform | Get Alert |
02/22/2024 | CE | Buy Now | Celanese | $162.31 | 10.9% | Wells Fargo | Michael Sison | $167 → $180 | Maintains | Overweight | Get Alert |
01/22/2024 | CE | Buy Now | Celanese | $162.31 | -1.42% | Alembic Global | Hassan Ahmed | → $160 | Downgrade | Overweight → Neutral | Get Alert |
01/16/2024 | CE | Buy Now | Celanese | $162.31 | -16.83% | B of A Securities | Steve Byrne | $124 → $135 | Downgrade | Neutral → Underperform | Get Alert |
01/11/2024 | CE | Buy Now | Celanese | $162.31 | 4.74% | UBS | Joshua Spector | $169 → $170 | Maintains | Buy | Get Alert |
01/09/2024 | CE | Buy Now | Celanese | $162.31 | 8.43% | Keybanc | Aleksey Yefremov | $29 → $13 | Maintains | Overweight | Get Alert |
12/14/2023 | CE | Buy Now | Celanese | $162.31 | 4.12% | UBS | Joshua Spector | $144 → $169 | Maintains | Buy | Get Alert |
12/13/2023 | CE | Buy Now | Celanese | $162.31 | -10.66% | Citigroup | Patrick Cunningham | $130 → $145 | Maintains | Neutral | Get Alert |
11/21/2023 | CE | Buy Now | Celanese | $162.31 | -16.83% | Piper Sandler | Charles Neivert | → $135 | Upgrade | Underweight → Neutral | Get Alert |
11/08/2023 | CE | Buy Now | Celanese | $162.31 | -12.51% | RBC Capital | Arun Viswanathan | $145 → $142 | Maintains | Outperform | Get Alert |
10/04/2023 | CE | Buy Now | Celanese | $162.31 | -18.06% | Citigroup | Patrick Cunningham | $130 → $133 | Maintains | Neutral | Get Alert |
10/03/2023 | CE | Buy Now | Celanese | $162.31 | -7.58% | Keybanc | Aleksey Yefremov | $149 → $150 | Maintains | Overweight | Get Alert |
09/06/2023 | CE | Buy Now | Celanese | $162.31 | -8.2% | Keybanc | Aleksey Yefremov | → $149 | Upgrade | Sector Weight → Overweight | Get Alert |
08/29/2023 | CE | Buy Now | Celanese | $162.31 | -31% | Piper Sandler | Charles Neivert | $120 → $112 | Downgrade | Neutral → Underweight | Get Alert |
08/11/2023 | CE | Buy Now | Celanese | $162.31 | -4.5% | Barclays | Michael Leithead | $146 → $155 | Maintains | Overweight | Get Alert |
08/10/2023 | CE | Buy Now | Celanese | $162.31 | -19.91% | Citigroup | Patrick Cunningham | $123 → $130 | Maintains | Neutral | Get Alert |
08/10/2023 | CE | Buy Now | Celanese | $162.31 | -10.66% | RBC Capital | Arun Viswanathan | $128 → $145 | Maintains | Outperform | Get Alert |
The latest price target for Celanese (NYSE: CE) was reported by RBC Capital on February 26, 2024. The analyst firm set a price target for $165.00 expecting CE to rise to within 12 months (a possible 1.66% upside). 37 analyst firms have reported ratings in the last year.
The latest analyst rating for Celanese (NYSE: CE) was provided by RBC Capital, and Celanese maintained their outperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Celanese, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Celanese was filed on February 26, 2024 so you should expect the next rating to be made available sometime around February 26, 2025.
While ratings are subjective and will change, the latest Celanese (CE) rating was a maintained with a price target of $168.00 to $165.00. The current price Celanese (CE) is trading at is $162.31, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.